CGC Canopy Growth Corporation
Canopy Growth Corporation, together with its subsidiaries, engages in the production, distribution, and sale of cannabis and cannabis-related products for medical and adult use in Canada, Germany, the United States, and …
Industry Peers
Drug Manufacturers - Specialty & Generic| Headline | Source | Time |
|---|---|---|
Older | ||
 Investors Heavily Search Canopy Growth Corporation (CGC): Here is What You Need to Know Recently, Zacks.com users have been paying close attention to Canopy Growth (CGC). This makes it worthwhile to examine what the stock has in store. | ||
 Canopy Growth Corporation (CGC) Rises Higher Than Market: Key Facts Canopy Growth Corporation (CGC) closed at $0.94 in the latest trading session, marking a +1.45% move from the prior day. | ||
 ServiceTitan (TTAN) Gains a Roofing Proof Point With Canopy. Can It Scale? Canopy Services is leveraging ServiceTitan Inc.’s (NASDAQ:TTAN) end-to-end roofing capabilities for its growing portfolico of roofing brands. The residential roofing platform is standardizing its core functions through ServiceTitan’s proprietary technology, and the move has already yielded encouraging results. Since adoption, Canopy has seen notable improvement in four key business metrics i.e. average ticket size, close […] | ||
 Here's Why Canopy Growth Corporation (CGC) Fell More Than Broader Market Canopy Growth Corporation (CGC) closed the most recent trading day at $0.94, moving 2.34% from the previous trading session. | ||
 Cellulosic Fibers Experience a Year in Flux Canopy's 2026 Hot Button Report assesses the sustainability of the largest global man-made cellulosic fiber producers. | ||
 Canopy Growth Is Eyeing Another Reverse Stock Split. Will It Be Enough to Light a Fire Beneath the Beaten-Down Pot Stock? Canopy Growth's stock has continued to fall, prompting the company to proactively seek to retain access to capital markets. | ||
 Fashion Has Plenty of Sustainable Coalitions. Could It Use One More? The Climate Pledge Fashion Coalition brings together more than 60 apparel and footwear players to aggregate demand, unlock investment and move lower-impact materials from pilots to commercial scale. | ||
 Canopy Growth Agrees UK Supply Deal for Four Medical Cannabis Strains Canopy Growth Corporation (NASDAQ:CGC) has announced an agreement with GROW Group U. K. | ||
 Canopy Growth Corporation (CGC) Outpaces Stock Market Gains: What You Should Know In the latest trading session, Canopy Growth Corporation (CGC) closed at $0.94, marking a +2.57% move from the previous day. | ||
Here is What to Know Beyond Why Canopy Growth Corporation (CGC) is a Trending Stock Canopy Growth (CGC) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects. | ||
 MO Stock: Altria Returned Billions To Shareholders. What’s The Catch? A tobacco giant sent a torrent of cash back to its owners. Here’s what that money actually bought, and what has to go right for the checks to keep coming. | ||
 Canopy Growth Corporation (CGC) Advances While Market Declines: Some Information for Investors Canopy Growth Corporation (CGC) reached $0.94 at the closing of the latest trading day, reflecting a +1.15% change compared to its last close. | ||
 Canopy Growth's Business Is Improving. So Why Isn't the Stock Performing Better? Two long-standing issues continue to weigh on this cannabis stock. | ||
 Canopy Growth's Revenue Grew 13% Last Quarter. Investors Barely Reacted. Here's Why. Revenue is growing, but the cannabis company still has a lot to prove to investors. | ||
 Should You Buy Canopy Growth Stock on the Rebound? Canopy Growth benefited from growth across all its divisions in the first quarter of fiscal 2027, but does that make it a worthwhile investment? | ||
 Better Cannabis Stock to Buy Right Now: Canopy Growth or Tilray Brands? The Canadian cannabis companies are both seeing strong growth, but one is a better buy right now. | ||
 Altria's Smoke-Free Ambition Has Quietly Narrowed To Its Nicotine Pouch Brand The transition Altria once said it would lead now rests on a single nicotine pouch brand, while the number it newly emphasizes is about defending cigarettes. | ||
 Cannabis Operator CGC Rises 15% in a Month: Time to Buy, Hold or Sell? Canopy Growth's cannabis business is showing signs of a turnaround, with revenue growth, improving margins and a narrower EBITDA loss fueling its rally. | ||
 Tilray Jumps 6%, Canopy Growth Climbs 3%, Aurora Cannabis Gains 4%: Here’s Why TLRY Is Still Down 47% YTD Tilray surged Wednesday alongside Canopy Growth and Aurora Cannabis, but one number from 2026 tells a very different story about why today's rally leaves the real problem untouched. | ||
 Curaleaf Wants to Buy Aurora Cannabis for $272 Million. Is Canopy Growth the Next Marijuana Takeover Target? Cannabis consolidation appears to be accelerating. | ||
 Canopy Growth (CGC) Q1 2027 Earnings Call Transcript Revenue grew 13% as MTL integration and Polish market strength drove results. | ||
 Will Canopy Growth Get Acquired? Curaleaf is attempting to acquire Canopy Growth's rival, Aurora Cannabis, and there could be more consolidation to come in the industry. | ||
 Canopy Growth Targets European Cannabis Expansion After MTL Deal and Cost Cuts Canopy Growth (NASDAQ:CGC) is positioning itself for further expansion in medical cannabis, European markets and Canadian recreational cannabis after restructuring operations, reducing costs and acquiring MTL Cannabis, President and CEO Luc Mongeau said during a Canaccord Genuity presentation. Mong | ||
 Canopy Growth: Penny Stock Purgatory -- or Cannabis Rebound in the Making? The turnaround is becoming more believable. | ||
Canopy Growth Corp (CGC) (Q1 2027) Earnings Call Highlights: Revenue Surges 13% and Gross ... Canopy Growth Corp (CGC) reports broad-based growth across all segments, with adjusted EBITDA loss improving 59% year-over-year. | ||
Weekly Roundup on the Cannabis Sector & Psychedelic Sector Key Takeaways; Cannabis Sector Canopy Growth Posted 13% Revenue Growth as Losses Narrowed Sharply in Q1 FY2027 Aurora Cannabis Narrowed Q1 Loss as International Medical Cannabis Growth Gained Ground Cronos Group Reported Record Q2 Revenue as Profitability and EBITDA Surged Key Takeaways; Psychedelic Sector Compass Pathways is Building Momentum Toward Potential COMP360 Launch as Veterans […] | ||
 Why Aurora Cannabis Looks Cheaper Than Its International Growth Suggests – Quarterly Update Report Download the Complete Report Here Aurora Cannabis Inc. (ACB) International Medical Growth Absorbs Much of Canadian Pricing Reset; Safari and Germany Momentum Strengthen the Medium-Term Growth Outlook. Attractively Valued. Key Takeaways: International medical cannabis revenue increased 17% to C$43.3 million in 1Q FY27, reinforcing ACB’s leadership across global medical markets. Adjusted gross margin reached 58%, […] The post Why Aurora Cannabis Looks Cheaper Than Its International Growth Suggests | ||